Publications

First-Line Bevacizumab plus Taxane-Based Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: Safety and Efficacy in an Open-Label Study in 2251 Patients

AuthID
P-002-TX2

Author(s)

Smith, IE

Pierga, JY

Biganzoli, L

Cortes Funes, H

Thomssen, C

Pivot, X

Fabi, A

Xu, B

Stroyakovskiy, D

Franke, FA

Kaufman, B

Mainwaring, P

Pienkowski, T

De Valk, B

Kwong, A

Gonzalez Trujillo, JL

Koza, I

Petrakova, K

Pereira, D

Pritchard, KI

Group Author(s)

ATHENA Study Grp

Document Type

Article

Year published

2011

Published

in ANNALS OF ONCOLOGY, ISSN: 0923-7534

Volume: 22, Issue: 3, Pages: 595-602 (8)

Indexing

Wos^®

Scopus^®

Crossref^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1093/annonc/mdq430

Pubmed: 20819780

Scopus: 2-s2.0-79952027747

Wos: WOS:000287750700014

Source Identifiers

ISSN: 0923-7534

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

First-Line Bevacizumab plus Taxane-Based Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: Safety and Efficacy in an Open-Label Study in 2251 Patients

Useful Links

Get Help

Federated Authentication (Click on the image)

First-Line Bevacizumab plus Taxane-Based Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: Safety and Efficacy in an Open-Label Study in 2251 Patients

Useful Links

Get Help